XML 20 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period Of Adoption, Adjustment
Cumulative Effect, Period Of Adoption, Adjustment
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative affect adjustment for Topic 842 adoption $ 1,111,199 $ 180 $ 2,093,834 $ (978,780) $ (4,035) $ (162) $ (162)
Beginning balance (in shares) at Dec. 31, 2018   180,175,000          
Beginning balance at Dec. 31, 2018 1,111,199 $ 180 2,093,834 (978,780) (4,035) (162) (162)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative affect adjustment for Topic 842 adoption $ 1,111,199 $ 188 2,238,782 (978,780) (4,035) $ (162) $ (162)
Common stock issued under employee stock plans (in shares) 3,000,000.0 3,003,000          
Common stock issued under employee stock plans $ 63,309 $ 3 63,306        
Taxes paid related to net share settlement of equity awards (247,620)   (247,620)        
Stock-based compensation 329,267   329,267        
Settlement of 2018 Warrants (in shares)   4,283,000          
Settlement of 2018 Warrants   $ 5 (5)        
Other comprehensive income (loss), net 17,577       17,577    
Net income (loss) (12,624)     (12,624)      
Ending balance (in shares) at Jun. 30, 2019   187,461,000          
Ending balance at Jun. 30, 2019 $ 1,260,946 $ 188 2,238,782 (991,566) 13,542    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201602Member            
Cumulative affect adjustment for Topic 842 adoption $ 1,194,951 $ 185 2,164,930 (980,487) 10,323    
Beginning balance (in shares) at Mar. 31, 2019   184,739,000          
Beginning balance at Mar. 31, 2019 1,194,951 $ 185 2,164,930 (980,487) 10,323    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative affect adjustment for Topic 842 adoption 1,260,946 $ 188 2,238,782 (991,566) 13,542    
Common stock issued under employee stock plans (in shares)   1,120,000          
Common stock issued under employee stock plans 10,207 $ 1 10,206        
Taxes paid related to net share settlement of equity awards (108,150)   (108,150)        
Stock-based compensation 171,798   171,798        
Settlement of 2018 Warrants (in shares)   1,602,000          
Settlement of 2018 Warrants $ 2 (2)        
Other comprehensive income (loss), net 3,219       3,219    
Net income (loss) (11,079)     (11,079)      
Ending balance (in shares) at Jun. 30, 2019   187,461,000          
Ending balance at Jun. 30, 2019 1,260,946 $ 188 2,238,782 (991,566) 13,542    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative affect adjustment for Topic 842 adoption 1,260,946 188 2,238,782 (991,566) 13,542    
Cumulative affect adjustment for Topic 842 adoption 2,127,941 $ 189 2,454,741 (352,244) 25,255    
Beginning balance (in shares) at Dec. 31, 2019   189,461,000          
Beginning balance at Dec. 31, 2019 2,127,941 $ 189 2,454,741 (352,244) 25,255    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative affect adjustment for Topic 842 adoption $ 2,478,806 $ 191 2,454,741 (352,244) 29,772    
Common stock issued under employee stock plans (in shares) 2,300,000 2,340,000          
Common stock issued under employee stock plans $ 91,054 $ 2 91,052        
Taxes paid related to net share settlement of equity awards (238,551)   (238,551)        
Stock-based compensation 405,739   405,739        
Settlement of 2022 Notes conversion feature (22,755)   (22,755)        
Benefit from exercise of 2022 Note Hedge 21,864   21,864        
Other comprehensive income (loss), net 4,517       4,517    
Net income (loss) 88,997     88,997      
Ending balance (in shares) at Jun. 30, 2020   191,801,000          
Ending balance at Jun. 30, 2020 2,478,806 $ 191 2,712,090 (263,247) 29,772    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative affect adjustment for Topic 842 adoption 2,266,095 $ 190 2,584,298 (304,013) (14,380)    
Beginning balance (in shares) at Mar. 31, 2020   190,700,000          
Beginning balance at Mar. 31, 2020 2,266,095 $ 190 2,584,298 (304,013) (14,380)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative affect adjustment for Topic 842 adoption 2,478,806 $ 191 2,712,090 (263,247) 29,772    
Common stock issued under employee stock plans (in shares)   1,101,000          
Common stock issued under employee stock plans 24,179 $ 1 24,178        
Taxes paid related to net share settlement of equity awards (112,845)   (112,845)        
Stock-based compensation 217,174   217,174        
Settlement of 2018 Warrants 0            
Settlement of 2022 Notes conversion feature (19,027)   (19,027)        
Benefit from exercise of 2022 Note Hedge 18,312   18,312        
Other comprehensive income (loss), net 44,152       44,152    
Net income (loss) 40,766     40,766      
Ending balance (in shares) at Jun. 30, 2020   191,801,000          
Ending balance at Jun. 30, 2020 2,478,806 $ 191 2,712,090 (263,247) 29,772    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative affect adjustment for Topic 842 adoption $ 2,478,806 $ 191 $ 2,712,090 $ (263,247) $ 29,772